Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Gepotidacin	767
Overall Study	STARTED	Nitrofurantoin	764
Overall Study	Safety Population	Gepotidacin	766
Overall Study	Safety Population	Nitrofurantoin	760
Overall Study	Microbiological ITT (Micro ITT) Population	Gepotidacin	401
Overall Study	Microbiological ITT (Micro ITT) Population	Nitrofurantoin	365
Overall Study	Micro-ITT NTF-S Population	Gepotidacin	336
Overall Study	Micro-ITT NTF-S Population	Nitrofurantoin	298
Overall Study	Micro-ITT NTF-S (IA Set) Population	Gepotidacin	320
Overall Study	Micro-ITT NTF-S (IA Set) Population	Nitrofurantoin	287
Overall Study	COMPLETED	Gepotidacin	734
Overall Study	COMPLETED	Nitrofurantoin	736
Overall Study	NOT COMPLETED	Gepotidacin	33
Overall Study	NOT COMPLETED	Nitrofurantoin	28

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04020341/flow